Clinical Trial

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Study acronym: AD
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to understand cellular and molecular interactions in the skin of participants with mild-to-moderate AD, and how botulinum toxin alters these interactions.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-07; most recent amendment 2026-05-01.
Status change: Not Yet Recruiting → Recruiting 2025-09-09
Trial Details
NCT Number NCT06928246
Lead Sponsor Daniel Kaplan
Collaborators: Almirall, S.A.
Conditions Atopic Dermatitis (AD)
Enrollment 8 participants
Start Date 2025-07-17
Primary Completion 2026-12-15 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-04